QMSR Is Done. Now What?

The FDA's Quality Management System Regulation (QMSR) aligns U.S. medical device oversight with ISO 13485:2016, establishing a unified global standard for quality management. While harmonization reduces redundant documentation and lowers internal audit costs, manufacturers must still address specific FDA expectations around post-market surveillance, unique device identification (UDI), and strict record controls.

Achieving long-term compliance requires shifting quality management from a reactive gatekeeper to a proactive partner across the product lifecycle. Moving quality involvement upstream into early supplier qualification, design planning, and complaint investigations prevents late-stage design changes and supply disruptions. Replacing lagging audit readiness metrics with leading process health indicators enables organizations to continuously monitor systemic risk and maintain inspection readiness. Watch the full presentation to learn actionable strategies for updating quality systems under the new QMSR framework.